In children, methotrexate (MTX) is used as an anti-inflammatory and immune-suppressing medicine (often for juvenile idiopathic arthritis or certain cancers). It affects the immune system mainly by slowing the growth and activity of immune cells and by changing inflammatory signals.
Key points:
- How it works
- It blocks a step called folate metabolism, which reduces the production of DNA in rapidly dividing cells like T and B lymphocytes. This lowers the number and activity of immune cells.
- At the low weekly doses used for autoimmune diseases, MTX also increases adenosine, a molecule that helps dampen inflammation.
- Effects on the immune system
- Immune-suppressive effect: can make it a bit easier to get infections and may blunt the body’s response to vaccines.
- Vaccination considerations: live vaccines (like MMR, varicella) are generally avoided while on MTX. Inactivated vaccines are usually safe but may be less effective; doctors often plan vaccinations before starting MTX or choose timing carefully.
- Rare but important risks: bone marrow suppression (which can lower white blood cell counts), liver inflammation or scarring (hepatic toxicity), and, less commonly, lung inflammation (pneumonitis).
- Monitoring and safety
- Regular blood tests (usually including a complete blood count and liver enzymes) and kidney function checks are common to watch for side effects.
- Report signs of infection right away: fever, chills, persistent coughing, frequent illnesses, or sores in the mouth.
- If an infection develops, the doctor may pause MTX until the infection resolves.
- Practical cautions
- NSAIDs and some other drugs can interact with MTX and raise toxicity risk; tell the medical team about every medicine your child takes.
- If your child has liver or kidney problems, or is very dehydrated, MTX dosing and safety need extra care.
Differences by dose:
- Low-dose MTX (used for arthritis and other autoimmune conditions) mainly acts as an anti-inflammatory with a modest effect on the immune system.
- High-dose MTX (used in some cancer regimens) causes more pronounced immune suppression and a higher infection risk; this is managed very carefully in the cancer setting.
If you want, tell me:
- What condition the child is being treated for (e.g., JIA, leukemia)?
- The MTX dose and schedule (weekly vs other)?
- Any vaccines planned or recent infections?
I can tailor the explanation to that situation and flag what to watch for and when to call the doctor. If there are immediate concerns (fever, trouble breathing, dehydration, or signs of infection), contact the child’s healthcare provider right away. This information is not a substitute for professional medical advice.